EX-99.1 2 d160709dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance ATLANTA, August 6, 2026 - Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation’s leading long-term care (“LTC”) pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2026. The Company also raised its full-year guidance. Second Quarter Financial Results Revenue of $351.8 million, up 2% year-over-year. Residents served ended the quarter at approximately 210,000, up 8% year-over-year. Net Income of $22.1 million, inclusive of a $8.5 million settlement related to a payor dispute, compared to $8.8 million in the prior-year period. Adjusted EBITDA of $29.7 million, compared to $25.0 million in the prior-year period. Diluted EPS of $0.34 for the quarter, with Adjusted EPS of $0.29.1 Cash and cash equivalents totaled $89.8 million at quarter-end, with no long-term debt outstanding under our credit facility. CEO Commentary “Guardian delivered another strong quarter, with continued momentum across our local markets,” said Fred Burke, Presiden…
Open exhibit ↗Current Report · Items 2.02, 9.01 · 8-K
Guardian Pharmacy Services, Inc.
GRDNNYSEEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 6, 2026, Guardian Pharmacy Services, Inc. (the “Company”) issued a press release reporting its financial results for the quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.…
Company context
Guardian Pharmacy Services is one of the nation’s leading long-term care pharmacy services companies. Through its locally-based business model, Guardian partners with long-term care facilities (“LTCFs”) to deliver medications and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. With a growing network of 61 licensed pharmacies, of which 54 are full-service, Guardian is dedicated to providing exceptional service to approximately 207,000 residents (as of March 31, 2026).